BRCA2 and cutaneous melanoma: A pan-cancer analysis done on 33 cancers including cutaneous melanoma and uveal melanoma observed significantly higher HRDsum scores calculated based on LOH, LST, and TAI in patients with 22 different HRR mutations including BRCA1 and BRCA2.